Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–11 of 11 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07635316
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor
- Locations
-
- Novartis East Hanover, New Jersey, United States
NCT07165132
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +24 more
- Locations
-
- Research Facility Iowa City, Iowa, United States
- Research Facility Lexington, Kentucky, United States
- Research Facility St Louis, Missouri, United States
- Research Facility St Louis, Missouri, United States
Recruiting
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
NCT05636618
- Conditions
- Bronchial Neuroendocrine Tumor, Central Nervous System Neoplasms, Gastro-enteropancreatic neuroendocrine tumor, +17 more
- Locations
-
- Mayo Clinic Jacksonville, Florida, United States
- Biogenix Molecular Miami, Florida, United States
- The University of Chicago Chicago, Illinois, United States
- University of Iowa Iowa City, Iowa, United States
NCT05477576
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +22 more
- Locations
-
- Research Facility Phoenix, Arizona, United States
- Research Facility Duarte, California, United States
- Research Facility Irvine, California, United States
- Research Facility Los Angeles, California, United States
NCT04090034
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor, Neoplasms, +5 more
- Locations
-
- Clinical Research Institute at Methodist Health System Dallas, Texas, United States
- Methodist Dallas Medical Center Dallas, Texas, United States
NCT04609592
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor
- Locations
-
- Stanford Cancer Institute Palo Alto Stanford, California, United States
NCT02611024
- Conditions
- Adenoma, Adnexal Diseases, Advanced Solid Tumors, +53 more
- Locations
-
- Sarcoma Oncology Center Santa Monica, California, United States
- Massachusetts General Hospital - Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- The University of Texas MD Anderson Cancer Center Houston, Texas, United States
Completed
Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
NCT02948946
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT03017690
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumor
- Locations
-
- The University of Arizona Cancer Center Tucson, Arizona, United States
- Ochsner Medical Center Kenner Kenner, Louisiana, United States
- Mercy Medical Center Baltimore, Maryland, United States
- National Translational Research Group East Setauket, New York, United States
Active, Not Recruiting
Neuroendocrine Tumors - Patient Reported Outcomes
NCT05064150
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +11 more
- Locations
-
- University of Florida Gainesville, Florida, United States
- University of Iowa Iowa City, Iowa, United States
- University of Kansas Medical Center Research Institute, Inc Kansas City, Kansas, United States
- Regents of the University of Michigan Ann Arbor, Michigan, United States
Active, Not Recruiting
NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas
NCT05262556
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +12 more
- Locations
-
- University hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States